LoadingLoadingLoadingNet selling: insiders sold $661K and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $19K to $159K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
Qube Research
$584.3M
bought
AQR
$469.1M
added
Sells/Trims (1)
Viking Global
$395.2M
sold
Buys (9)
No tracked top-trader positions in UNH as of Oct 22, 22:40 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Oct 13, 2026
Financial period
Q3 2026
Earnings per share
$4.14 expected
Revenue
$111.49B expected
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 13, 2026 | $4.69 / $4.14Yahoo Finance | +13.26% beat | $112.70B $111.49B expected | +1.09% beat |
| Jun 30, 2026 | Jul 16, 2026 | $6.38 / $4.92Yahoo Finance | +29.80% beat | $112.03B No estimateSEC filing | Unavailable |
| Mar 31, 2026 | Apr 21, 2026 | $7.23 / $6.60Yahoo Finance | +9.52% beat | $111.72B No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Jan 27, 2026 | $2.11 / $2.11Yahoo Finance | +0.19% in line | $113.22B No estimate | Unavailable |
| Sep 30, 2025 | Oct 28, 2025 | $2.92 / $2.81Alpha Vantage | +3.91% beat | $113.16B No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Jul 29, 2025 | $4.08 / $4.45Alpha Vantage | -8.31% miss | $111.62B No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 17, 2025 | $7.20 / $7.29Alpha Vantage | -1.23% miss | $109.58B No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Jan 16, 2025 | $6.81 / $6.74Alpha Vantage | +1.04% beat | $100.81B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $113.16B | $113.22B | $111.72B | $112.03B |
| Cost of what it sold | $92.52B | $94.72B | $86.31B | $75.36B |
| Gross profit | $20.64B | $18.49B | $25.41B | $36.67B |
| What it spent | ||||
| Sales and admin | $15.22B | $17.00B | $15.39B | — |
| Other operating costs | $1.10B | $1.12B | $1.03B | $28.68B |
| Total operating expenses | $16.32B | $18.11B | $16.42B | $28.68B |
| What was left | ||||
| Operating profit | $4.32B | $380.0M | $8.99B | $7.99B |
| Interest on debt | $1.00B | $974.0M | $955.0M | $962.0M |
| Profit before tax | $3.23B | -$720.0M | $7.96B | $6.97B |
| Tax | $686.0M | -$938.0M | $1.48B | $1.30B |
| Net profit | $2.35B | $10.0M | $6.28B | $5.48B |
| EBITDA | $5.33B | $1.37B | $10.09B | $8.97B |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Cigna Group stock: UBS keeps buy rating for Cigna Group stock
Leans bearishOct 21UnitedHealth Group stock: Piper Sandler lifts target to USD 504.00
BullishOct 21KT partners with Acryl to develop customized healthcare AI services
Leans bullishOct 21Elevance Health Crushes Q3 2026 Profit Estimates by 47.8%
Leans bullishOct 21UnitedHealth Leaders Say Costs ‘Remain Stubbornly High’
Leans bearishOct 21Amazon, Twilio, eBay And A Health Care Stock: CNBC’s ‘Final Trades’
BullishOct 21UnitedHealth raises outlook. UnitedHealth Group stock sits 0.40 percent below Xetra close
Leans bullishOct 21Health insurance companies cancel nearly 1M Medicare Advantage plans — here’s what it means for you
Leans bearishOct 21
